1,065
Participants
Start Date
December 19, 2019
Primary Completion Date
February 13, 2032
Study Completion Date
February 13, 2032
Tumor Imaging
Participants will undergo tumor imaging using either a magnetic resonance imaging (MRI) scan or a computed tomography (CT) scan.
Tumor Tissue Collection
Participants without archival tumor tissue samples will undergo tumor tissue collection for newly obtained tumor tissue.
Blood Sample Collection
"Participants will have blood samples drawn for analysis of:~* genetics~* ribonucleic acid (RNA)~* serum biomarker~* plasma biomarker~* circulating tumor DNA (ctDNA)"
RECRUITING
Orszagos Koranyi Pulmonologiai Intezet ( Site 0060), Budapest
RECRUITING
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 0061), Szolnok
RECRUITING
Petz Aladar Megyei Oktato Korhaz ( Site 0062), Győr
RECRUITING
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0034), New York
RECRUITING
Seoul National University Bundang Hospital ( Site 0081), Seongnam-si
RECRUITING
Abramson Cancer Center of the University of Pennsylvania ( Site 0010), Philadelphia
COMPLETED
Georgetown University ( Site 0036), Washington D.C.
RECRUITING
IRCCS Ospedale San Raffaele ( Site 0171), Milan
ACTIVE_NOT_RECRUITING
MedStar Franklin Square Medical Center ( Site 0033), Baltimore
RECRUITING
Hospital Universitario Quiron Madrid ( Site 0091), Madrid
RECRUITING
Ohio State University Comprehensive Cancer Center ( Site 0015), Columbus
RECRUITING
Cleveland Clinic Main ( Site 0006), Cleveland
RECRUITING
Azienda Ospedaliera Universitaria Careggi ( Site 0173), Florence
RECRUITING
Sanford Cancer Center ( Site 0038), Sioux Falls
RECRUITING
Sanford Fargo Medical Center ( Site 0039), Fargo
RECRUITING
Oncology Hematology West, PC DBA Nebraska Cancer Specialists ( Site 0031), Omaha
RECRUITING
The University of Texas MD Anderson Cancer Center ( Site 0009), Houston
RECRUITING
Banner MD Anderson Cancer Center ( Site 0001), Gilbert
COMPLETED
City of Hope ( Site 0014), Duarte
COMPLETED
UCSF Medical Center at Mission Bay ( Site 0007), San Francisco
RECRUITING
Rambam Health Care Campus-Oncology ( Site 0076), Haifa
RECRUITING
Meir Medical Center ( Site 0071), Kfar Saba
RECRUITING
Rabin Medical Center ( Site 0074), Petah Tikva
RECRUITING
Chaim Sheba Medical Center ( Site 0070), Ramat Gan
RECRUITING
Sourasky Medical Center ( Site 0077), Tel Aviv
COMPLETED
Soroka Medical Center ( Site 0072), Beersheba
RECRUITING
Shaare Zedek Medical Center ( Site 0075), Jerusalem
RECRUITING
University of Kentucky Markey Cancer Center ( Site 0019), Lexington
RECRUITING
Massachusetts General Hospital ( Site 0003), Boston
RECRUITING
Dana Farber Cancer Institute ( Site 0002), Boston
RECRUITING
Dartmouth Hitchcock Medical Center ( Site 0016), Lebanon
COMPLETED
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0037), Hackensack
RECRUITING
Policlinico Gemelli di Roma ( Site 0174), Roma
RECRUITING
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 0151), Warsaw
RECRUITING
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150), Gdansk
ACTIVE_NOT_RECRUITING
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0152), Koszalin
RECRUITING
Severance Hospital ( Site 0080), Seoul
RECRUITING
Samsung Medical Center ( Site 0082), Seoul
RECRUITING
ICO L Hospitalet ( Site 0090), L'Hospitalet de Llobregat
RECRUITING
Hospital Clínic de Barcelona ( Site 0092), Barcelona
Collaborators (1)
Daiichi Sankyo
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY